NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Venture Global, Inc (“Venture Global” or the “Company”) (NYSE: VG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or “Company”) announces that it has entered into debt settlement agreements…

NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capri Holdings Limited (“Capri” or the “Company”) (NYSE: CPRI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…

NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Caribou Biosciences, Inc. (“Caribou” or the “Company”) (NASDAQ: CRBU) and certain officers. The class action, filed in the United States District Court for the Northern…

NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) and certain officers. The class action, filed in the United States District Court for the Middle…

NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Innovative Industrial Properties, Inc. (“IIPR”, “IIP”, or the “Company”) (NYSE: IIPR) and certain officers. The class action, filed in the United States District Court for…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.